TAILIEUCHUNG - Patients with coronary artery bifurcation lesions treated by Axxess stent implantation

To compare the result and safety of the Axxess biolimus-eluting stent with the second-generation drug-eluting stent (DES) in the treatment of bifurcation lesions. The result and safety of the Axxess biolimus-eluting stent were better than DES in treating bifurcation lesions. The present study suggests that the Axxess stent may represent a valid alternative approach for treating bifurcation lesions. | Journal OF MILITARY PHARMACO - MEDICINE N06 - 2021 PATIENTS WITH CORONARY ARTERY BIFURCATION LESIONS TREATED BY AXXESS STENT IMPLANTATION Le Thanh Binh1 2 Pham Manh Hung2 Nguyen Oanh Oanh3 SUMMARY Objectives To compare the result and safety of the Axxess biolimus-eluting stent with the second-generation drug-eluting stent DES in the treatment of bifurcation lesions. Subjects and methods Between May 2014 and December 2017 141 patients with de novo bifurcation lesions were treated with the Axxess stent Axxess group 51 patients and without the Axxess stent Control group 90 patients treated with DES . The primary objectives were 1 the device the angiographic and the procedural success rate and 2 the trouble in side branch SB access and the procedural complication rate including SB occlusion . Results Device success was obtained in all patients in both groups. Angiographic success was obtained in 50 patients in the Axxess group and in 80 patients in the control group p . Procedural success was obtained in 50 patients in the Axxess group and in 80 patients in the control group p . Trouble in SB access did not occur in the Axxess group but in 19 patients in the control group p lt . Procedural complications occurred in 1 patient in the Axxess group and in 10 patients in the control group p . Conclusion The result and safety of the Axxess biolimus-eluting stent were better than DES in treating bifurcation lesions. The present study suggests that the Axxess stent may represent a valid alternative approach for treating bifurcation lesions. Keywords Coronary bifurcation lesions Axxess stent. INTRODUCTION Biosensors International Morges Switzerland Fig. 1 is a dedicated The main vessel MV stenting and bifurcation stent designed to cover the provisional side branch SB stenting lesion at the level of the carina 4 5 6 . technique is the preferred approach for The present study is a prospective two- the treatment of

• Y khoa - Dược
• Coronary bifurcation lesions
• Axxess biolimus eluting stent
• Drug eluting stent
• Treating bifurcation lesions
• Main vessel
• Bifurcation lesions
• Intravascular contrast agents
• Elective coronary intervention
• Chronic total occlusions
• Arterial injury
• Vascular biology